Propiedades psicométricas y utilidad diagnóstica del Addenbrooke’s Cognitive Examination-Revised (ACE-R) en una muestra de ancianos chilenos
Author
dc.contributor.author
Muñoz Neira, Carlos
Author
dc.contributor.author
Henríquez Ch., Fernando
es_CL
Author
dc.contributor.author
Ihnen, Josefina
es_CL
Author
dc.contributor.author
Sánchez C., Mauricio
es_CL
Author
dc.contributor.author
Flores M., Patricia
es_CL
Author
dc.contributor.author
Slachevsky Chonchol, Andrea
es_CL
Admission date
dc.date.accessioned
2014-01-08T13:49:40Z
Available date
dc.date.available
2014-01-08T13:49:40Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Rev Med Chile 2012; 140: 1006-1013
en_US
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129107
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Background: The Addenbrooke’s Cognitive Examination - Revised (ACE-R)
is a good alternative to the Mini Mental State Examination (MMSE) for assessing
cognitive capacities in dementia. Aim: To estimate the psychometric properties and
diagnostic utility of the Addenbrooke’s Cognitive Examination-Revised (ACE-R)
in a Chilean elderly sample. Material and Methods: ACE-R was adapted for the
Chilean population (ACE-R-Ch) and then administered to 60 dementia patients,
22 mild cognitive impairment (MCI) patients and 45 control subjects in addition to
the MMSE for assessing global cognitive efficiency. Caregivers of dementia patients
and collateral sources of MCI patients and elderly subjects without dementia were
interviewed with measures of dementia severity, functional status in activities of daily
living and cognitive changes. Convergent validity, internal consistency reliability, cutoff
points, sensitivity and specificity for ACE-R-Ch were estimated. Results: Regarding
convergent validity, the ACE-R-Ch showed significant correlations (p < 0,001) with
another cognitive measure (r = 0,952 with MMSE), a rating for dementia severity
(Spearman rho=-0,822 with CDR), functional capacity assessments (r = -0,70
with ADLQ-Ch; r = -0,725 with PFAQ-Ch; and r = 0,650 with IADL Scale) and a
measure of cognitive changes (r = -0,633 with AD8-Ch). In terms of reliability, the
test had a Cronbach alpha coefficient of 0.918. The best cut-off point to distinguish
cases of dementia from control subjects was a score of 76, which reached a sensitivity
of 0.92 and a specificity of 0.93. Conclusions: The ACE-R-Ch showed acceptable
psychometric properties, becoming a valid and reliable instrument to assess global
cognitive efficiency or cognitive impairment. Its diagnostic utility to detect dementia
patients also worked very well in a Chilean elderly sample.